Wrist Fracture Linked to Higher Subsequent Fracture Risk

This article originally appeared here.
Share this content:
Wrist Fracture Linked to Higher Subsequent Fracture Risk
Wrist Fracture Linked to Higher Subsequent Fracture Risk

MONDAY, Oct. 26, 2015 (HealthDay News) -- For postmenopausal women, wrist fracture is associated with increased risk of subsequent non-wrist fracture, according to a study published in the November issue of the Journal of Bone and Mineral Research.

Carolyn J. Crandall, M.D., from the David Geffen School of Medicine at the University of California Los Angeles, and colleagues examined the frequency and type of fractures that occur after a wrist fracture among postmenopausal women. A post-hoc analysis of data from the Women's Health Initiative Observational Study and Clinical Trials was conducted. Participants, aged 50 to 79 years, were followed for a mean of 11.8 years.

The researchers found that 15.5 percent of the women who experienced wrist fracture subsequently experienced non-wrist fracture. Compared with those who had not experienced wrist fracture, women who had experienced previous wrist fracture had increased risk for non-wrist fracture (hazard ratios: 1.40 overall; 1.48 for spine; 1.78 for humerus; 1.88 for upper extremity; 1.36 for lower extremity; and 1.50 for hip). After adjustment for bone mineral density, physical activity, and other risk factures, the associations persisted. In women who were younger when they experienced wrist fracture, the risk of non-wrist fracture was higher (interaction P = 0.02).

"There may be substantial missed opportunity for intervention in the large number of women who present with wrist fractures," the authors write.

Two authors disclosed financial ties to Amgen.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »